Newsroom
Biotech investors: Stop expecting CRISPR science to make big leaps
CRISPR technologies have tremendous potential to improve the health of patients with hard-to-cure or incurable illnesses. There are many valuable wins we can achieve for patients suffering from the most intractable cancers, where the science advances in small, non-glamorous increments yet the lifesaving impact for patients could not be more significant. Join leaders in the field Eric Kmiec, Ph.D., and Kelly Banas, Ph.D., as they examine the current layout of the field, the benchmarks of science compared to the challenges of investment, and their hopes for a scientific field that examines CRISPR with rigor and caution.
Browse more Stories
NEWS 10 October 2024
Women of Influence 2024: How 36 businesswomen are shaping Greater Philadelphia
NEWS 11 September 2024
Delaware Tech: A National Leader in Gene-Editing Research
.jpg)
NEWS 5th June 2024
Where does Delaware fit with the regional precision medicine hub?
Upcoming Presentations
Press Releases
PRESS 17 June 2025
Gene Editing Institute Celebrates 10 Years of Innovation, Impact and Discovery
“This anniversary is more than a reflection on the past — it’s a launchpad for the future. And if the last 10 years are any indication, the next 10 will be nothing short of extraordinary.”
With those words, Jennifer Schwartz, Esq., chief strategy and legal officer at ChristianaCare, kicked off a vibrant celebration on June 12, marking the 10th anniversary of the Gene Editing Institute.
PRESS 18 December 2024
ChristianaCare’s Gene Editing Institute Earns Prestigious Spot on The Scientist’s Top 10 Innovations List for CRISPR in a Box™
ChristianaCare’s Gene Editing Institute’s CRISPR in a Box™ teaching toolkit has been named the #2 innovation on The Scientist’s Top 10 Innovations list for 2024. This cutting-edge toolkit has already empowered over 1,000 students this year, providing a hands-on experience with one of the most exciting technologies in modern science.
PRESS 15 October 2024
Scientists Use CRISPR Tools to Safely Disable Gene Mutation Linked to Advanced Skin Cancer
In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of this dangerous skin cancer that renders promising treatments ineffective.
Need more information?
For press inquiries, please contact William Schmitt at WSchmitt@Christianacare.org. For inquiries about presentations and events, email geneeditinginstitute@christianacare.org.
